Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Dig Dis Sci. 2020 Jan 14;65(11):3159–3174. doi: 10.1007/s10620-019-06037-z

Table A3.

Total number of treatment initiations during the post-DAA period (n= 14,896).

Variable HCV (n= 14,467) % HCV/HIV (n= 429) % Total %
Untreated 9,639 66.6 288 67.1 9,927 66.6
Dual therapy 6 0.0 1 0.2 7 0.0
Triple therapy 179 1.2 8 1.9 187 1.3
All-oral therapy 4,643 32.1 132 30.8 4,775 32.1